Nitric oxide (NO) serves as a retrograde messenger to activate neuronal NO synthase in the spinal cord via NMDA receptors

Nitric Oxide - Biology and Chemistry

Volumn 17, Issue 1, 2007, Pages 18-24

  Xu, Li ^a   Mabuchi, Tamaki ^a   Katano, Tayo ^a   Matsumura, Shinji ^a   Okuda Ashitaka, Emiko ^a   Sakimura, Kenji ^b   Mishina, Masayoshi ^c   Ito, Seiji ^a  

^a KANSAI MEDICAL UNIVERSITY   (Japan)

^b NIIGATA UNIVERSITY   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

Author keywords

NADPH diaphorase; Neuronal nitric oxide synthase (nNOS); Nitric oxide (NO); NMDA receptors; NO donor; Spinal cord

Indexed keywords

CYCLIC GMP; DIZOCILPINE; FORSKOLIN; KT 5823; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE DEHYDROGENASE; TRAXOPRODIL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; MALE; MOUSE; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SPINAL CORD; STAINING;

ANIMALS; CARBAZOLES; CYCLIC GMP; DIZOCILPINE MALEATE; INDOLES; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; NEURONS; NEUROPROTECTIVE AGENTS; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE I; PIPERIDINES; RECEPTORS, N-METHYL-D-ASPARTATE; SPINAL CORD;

MUS;

EID: 34447321033     PISSN: 10898603     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.niox.2007.04.004     Document Type: Article

References (44)

1. Snyder S.H. Nitric oxide: first in a new class of neurotransmitters?. Science 257 (1992) 494-496
2. Moncada S., and Higgs A. The l-arginine-nitric oxide pathway. N. Engl. J. Med. 329 (1993) 2002-2012
3. Prast H., and Philippu A. Nitric oxide as modulator of neuronal function. Prog. Neurobiol. 64 (2001) 51-68
4. Meller S.T., and Gebhart G.F. Nitric oxide (NO) and nociceptive processing in the spinal cord. Pain 52 (1993) 127-136
5. Ji R.-R., Kohno T., Moore K.A., and Woolf C.J. Central sensitization and LTP: do pain and memory share similar mechanisms?. Trends Neurosci. 26 (2003) 696-705
6. Knowles R.G., Palacios M., Palmer R.M.J., and Moncada S. Formation of nitric oxide from l-arginine in the central nervous system: A transduction mechanism for stimulation of the soluble guanylate cyclase. Proc. Natl. Acad. Sci. USA 86 (1989) 5159-5162
7. Wu J., Lin Q., Lu Y., Willis W.D., and Westlund K.N. Changes in nitric oxide synthase isoforms in the spinal cord of rat following induction of chronic arthritis. Exp. Brain Res. 118 (1998) 457-465
8. Lam H.H., Hanley D.F., Trapp B.D., Saito S., Raja S., Dawson T.M., and Yamaguchi H. Induction of spinal cord neuronal nitric oxide synthase (NOS) after formalin injection in the rat hind paw. Neurosci. Lett. 210 (1996) 201-204
9. Herdegen T., Rüdiger S., Mayer B., Bravo R., and Zimmermann M. Expression of nitric oxide synthase and colocalisation with Jun, Fos and Krox transcription factors in spinal cord neurons following noxious stimulation of the rat hindpaw. Mol. Brain Res. 22 (1994) 245-258
10. Garry M.G., Richardson J.D., and Hargreaves K.M. Carrageenan-induced inflammation alters the content of i-cGMP and i-cAMP in the dorsal horn of the spinal cord. Brain Res. 646 (1994) 135-139
11. Lincoln T.M., and Cornwell T.L. Intracellular cyclic GMP receptor proteins. FASEB J. 7 (1993) 328-338
12. Wang X., and Robinson P.J. Cyclic GMP-dependent protein kinase and cellular signaling in the nervous system. J. Neurochem. 68 (1997) 443-456
13. Qian Y., Chao D.S., Santillano D.R., Cornwell T.L., Nairn A.C., Greengard P., Lincoln T.M., and Bredt D.S. cGMP-dependent protein kinase in dorsal root ganglion: relationship with nitric oxide synthase and nociceptive neurons. J. Neurosci. 16 (1996) 3130-3138
14. Tao Y.-X., Hassan A., Haddad E., and Johns R.A. Expression and action of cyclic GMP-dependent protein kinase Iα in inflammatory hyperalgesia in rat spinal cord. Neuroscience 95 (2000) 525-533
15. Meller S.T., Dykstra C., and Gebhart G.F. Production of endogenous nitric oxide and activation of soluble guanylate cyclase are required for N-methyl-d-aspartate- produced facilitation of the nociceptive tail-flick reflex. Eur. J. Pharmacol. 214 (1992) 93-96
16. Sluka K.A., and Willis W.D. Increased spinal release of excitatory amino acids following intradermal injection of capsaicin is reduced by a protein kinase G inhibitor. Brain Res. 798 (1998) 281-286
17. 2α in conscious mice. Pain 61 (1995) 285-290
18. Tao Y.-X., and Johns R.A. Activation of cGMP-dependent protein kinase Iα is required for N-methyl-d-aspartate- or nitric oxide-produced spinal thermal hyperalgesia. Eur. J. Pharmacol. 392 (2000) 141-145
19. Schmidtko A., Ruth P., Geisslinger G., and Tegeder I. Inhibition of cyclic guanosine 5'-monophosphate-dependent protein kinase I (PKG-I) in lumbar spinal cord reduces formalin-induced hyperalgesia and PKG upregulation. Nitric Oxide 8 (2003) 89-94
20. Estévez A.G., Spear N., Manuel S.M., Radi R., Henderson C.E., Barbeito L., and Beckman J.S. Nitric oxide and superoxide contribute to motor neuron apoptosis induced by trophic factor deprivation. J. Neurosci. 18 (1998) 923-931
21. Estévez A.G., Kamaid A., Thompson J.A., Cornwell T.L., Radi R., Barbeito L., and Beckman J.S. Cyclic guanosine 5' monophosphate (GMP) prevents expression of neuronal nitric oxide synthase and apoptosis in motor neurons deprived of trophic factors in rats. Neurosci. Lett. 326 (2002) 201-205
22. Hartell N.A. cGMP acts within cerebellar Purkinje cells to produce long term depression via mechanisms involving PKC and PKG. Neuroreport 5 (1994) 833-836
23. Calabresi P., Gubellini P., Centonze D., Sancesario G., Morello M., Giorgi M., Pisani A., and Bernardi G. A critical role of the nitric oxide/cGMP pathway in corticostriatal long-term depression. J. Neurosci. 19 (1999) 2489-2499
24. Zhuo M., Hu Y., Schultz C., Kandel E.R., and Hawkins R.D. Role of guanylyl cyclase and cGMP-dependent protein kinase in long-term potentiation. Nature 368 (1994) 635-639
25. Santschi L., Reyes-Harde M., and Stanton P.K. Chemically induced, activity- independent LTD elicited by simultaneous activation of PKG and inhibition of PKA. J. Neurophysiol. 82 (1999) 1577-1589
26. Arancio O., Kandel E.R., and Hawkins R.D. Activity-dependent long-term enhancement of transmitter release by presynaptic 3',5'-cyclic GMP in cultured hippocampal neurons. Nature 376 (1995) 74-80
27. Hope B.T., Michael G.J., Knigge K.M., and Vincent S.R. Neuronal NADPH diaphorase is a nitric oxide synthase. Proc. Natl. Acad. Sci. USA 88 (1991) 2811-2814
28. Dawson T.M., Bredt D.S., Fotuhi M., Hwang P.M., and Snyder S.H. Nitric oxide synthase and neuronal NADPH diaphorase are identical in brain and peripheral tissues. Proc. Natl. Acad. Sci. USA 88 (1991) 7797-7801
29. Xu L., Matsumura S., Mabuchi T., Takagi K., Abe T., and Ito S. In situ measurement of neuronal nitric oxide synthase activity in the spinal cord by NADPH-diaphorase histochemistry. J. Neurosci. Methods 150 (2006) 174-184
30. Mabuchi T., Matsumura S., Okuda-Ashitaka E., Kitano T., Kojima H., Nagano T., Minami T., and Ito S. Attenuation of neuropathic pain by the nociceptin/orphanin FQ antagonist JTC-801 is mediated by inhibition of nitric oxide production. Eur. J. Neurosci. 17 (2003) 1384-1392
31. Mabuchi T., Shintani N., Matsumura S., Okuda-Ashitaka E., Hashimoto H., Muratani T., Minami T., Baba A., and Ito S. Pituitary adenylate cyclase-activating polypeptide is required for the development of spinal sensitization and induction of neuropathic pain. J. Neurosci. 24 (2004) 7283-7291
32. Abe T., Matsumura S., Katano T., Mabuchi T., Takagi K., Xu L., Yamamoto A., Hattori K., Yagi T., Watanabe M., Nakazawa T., Yamamoto T., Mishina M., Nakai Y., and Ito S. Fyn kinase-mediated phosphorylation of NMDA receptor NR2B subunit at Tyr1472 is essential for maintenance of neuropathic pain. Eur. J. Neurosci. 22 (2005) 1445-1454
33. Sakimura K., Kutsuwada T., Ito I., Manabe T., Takayama C., Kushiya E., Yagi T., Aizawa S., Inoue Y., Sugiyama H., and Mishina M. Reduced hippocampal LTP and spatial learning in mice lacking NMDA receptor ε1 subunit. Nature 373 (1995) 151-155
34. Ikeda K., Araki K., Takayama C., Inoue Y., Yagi T., Aizawa S., and Mishina M. Reduced spontaneous activity of mice defective in the ε4 subunit of the NMDA receptor channel. Mol. Brain Res. 33 (1995) 61-71
35. Nakanishi S. Molecular diversity of glutamate receptors and implications for brain function. Science 258 (1992) 597-603
36. Mori H., and Mishina M. Structure and function of the NMDA receptor channel. Neuropharmacology 34 (1995) 1219-1237
37. Fukuyama S., Hirasawa Y., Kato Y., Nishio M., Ohno M., Nishino S., Maeda K., Kato M., and Kita Y. Structure-activity relationships of spontaneous nitric oxide releasers, FK409 and its derivatives. J. Pharmacol. Exp. Ther. 282 (1997) 236-242
38. Chaki S., and Inagami T. New signaling mechanism of angiotensin II in neuroblastoma neuro-2A cells: activation of soluble guanylyl cyclase via nitric oxide synthesis. Mol. Pharmacol. 43 (1993) 603-608
39. Arundine M., Sanelli T., He B.P., and Strong M.J. NMDA induces NOS 1 translocation to the cell membrane in NGF-differentiated PC 12 cells. Brain Res. 976 (2003) 149-158
40. Montague P.R., Gancayco C.D., Winn M.J., Marchase R.B., and Friedlander M.J. Role of NO production in NMDA receptor-mediated neurotransmitter release in cerebral cortex. Science 263 (1994) 973-977
41. Guevara-Guzman R., Emson P.C., and Kendrick K.M. Modulation of in vivo striatal transmitter release by nitric oxide and cyclic GMP. J. Neurochem. 62 (1994) 807-810
42. Ohkuma S., and Katsura M. Nitric oxide and peroxynitrite as factors to stimulate neurotransmitter release in the CNS. Prog. Neurobiol. 64 (2001) 97-108
43. Jaffrey S.R., Erdjument-Bromage H., Ferris C.D., Tempst P., and Snyder S.H. Protein S-nitrosylation: a physiological signal for neuronal nitric oxide. Nat. Cell Biol. 3 (2001) 193-197
44. O'Dell T.J., Hawkins R.D., Kandel E.R., and Arancio O. Tests of the roles of two diffusible substances in long-term potentiation: Evidence for nitric oxide as a possible early retrograde messenger. Proc. Natl. Acad. Sci. U.S.A. 88 (1991) 11285-11289